Northwest Biotherapeutics, Inc. (NWBO)
0.1696
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Northwest Biotherapeutics Market Cap : 283.20M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 283.20M |
| September 03, 2026 | 283.63M |
| September 02, 2026 | 282.78M |
| September 01, 2026 | 280.44M |
| August 31, 2026 | 284.07M |
| August 28, 2026 | 316.50M |
| August 27, 2026 | 299.04M |
| August 26, 2026 | 288.79M |
| August 25, 2026 | 290.29M |
| August 24, 2026 | 287.92M |
| August 21, 2026 | 283.11M |
| August 20, 2026 | 285.88M |
| August 19, 2026 | 296.38M |
| August 18, 2026 | 300.31M |
| August 17, 2026 | 304.65M |
| August 14, 2026 | 320.51M |
| August 13, 2026 | 317.17M |
| August 12, 2026 | 315.16M |
| August 11, 2026 | 305.31M |
| August 10, 2026 | 298.88M |
| August 07, 2026 | 295.03M |
| August 06, 2026 | 286.83M |
| August 05, 2026 | 263.53M |
| August 04, 2026 | 258.71M |
| August 03, 2026 | 256.30M |
| Date | Value |
|---|---|
| July 31, 2026 | 263.53M |
| July 30, 2026 | 265.14M |
| July 29, 2026 | 260.32M |
| July 28, 2026 | 275.41M |
| July 27, 2026 | 278.95M |
| July 24, 2026 | 275.87M |
| July 23, 2026 | 271.73M |
| July 22, 2026 | 279.24M |
| July 21, 2026 | 274.11M |
| July 20, 2026 | 284.42M |
| July 17, 2026 | 271.12M |
| July 16, 2026 | 246.66M |
| July 15, 2026 | 265.94M |
| July 14, 2026 | 276.23M |
| July 13, 2026 | 289.72M |
| July 10, 2026 | 286.03M |
| July 09, 2026 | 285.79M |
| July 08, 2026 | 295.67M |
| July 07, 2026 | 294.80M |
| July 06, 2026 | 301.78M |
| July 02, 2026 | 297.60M |
| July 01, 2026 | 294.06M |
| June 30, 2026 | 300.18M |
| June 29, 2026 | 297.28M |
| June 26, 2026 | 311.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.823B |
| Alnylam Pharmaceuticals, Inc. | 35.59B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
| Vericel Corp. | 2.057B |
Market Cap Related Metrics
| PS Ratio | 122.71 |
| Price | 0.1696 |
| Earnings Yield | -14.97% |